Vulvar Cancer Market Worldwide Trend in Healthcare Sectors by Leading Players: Simulab Corporation (U.S.), Simulaids Inc. (U.S.), Etc by 2023
The Global Vulvar Cancer Market is expected to grow at a CAGR of 5.8% during forecasted period of 2017-2023. Vulvar cancer is a rare disease that comprises of a malignant and invasive growth in the vulva. Being a rare disease it accounts for only 0.6- 0.7 % of total cancer diagnosis. Labia majora is the common site of this cancer as compared to labia minora. The major driving factor for this market is increasing prevalence of different types of like...
View full press release